期刊文献+

氪黄激光治疗糖尿病性视网膜病变黄斑水肿 被引量:5

Krypton yellow laser photocoagulation for macular edema of diabetic retinopathy
原文传递
导出
摘要 目的 :评价氪黄激光治疗糖尿病性视网膜病变黄斑水肿的临床疗效。方法 :用氪黄激光治疗糖尿病性视网膜病变黄斑水肿共 34例 (48眼 ) ,氪黄激光波长 5 6 8nm,对黄斑区局部水肿采用局部光凝 ,弥漫性水肿采用 C形格栅状光凝 ,光凝距黄斑中心小凹 30 0 μm,避开视盘黄斑束 ,功率 6 0~ 2 0 0 m w,光斑直径 10 0 μm,曝光时间 0 .1s,光凝 6 8~ 189点 ,光斑反应 — 级。术后平均随访 10个月。结果 :术后视力提高者 33眼 (6 8.8% ) ,不变者 13眼 (2 7.1% ) ,下降者 2眼 (4.2 % )。光凝后黄斑水肿完全消退者 15眼 (31.3% ) ,部分消退者 2 8眼 (5 8.3% ) ,不变者 5眼 (10 .4% )。无明显并发症。结论 :氪黄激光治疗糖尿病性视网膜病变黄斑水肿安全。 Objective: To evaluate the clinical effects of krypton yellow laser photocoagulation for macular edema in diabetic retinopathy. Methods: 48 eyes (34 cases) of diabetic retinopathy with macular edema were treated with local or grid macular krypton yellow photocoagulation. The course of followed-up was 10 months. Results: The visual acuities were 0.17(0.19 before treatment and 0.37(0.28 after treatment (P<0. 01), were increased in 68.8% of the subject eyes, stable in 27.l and decreased in 4.2%. Macular edema disappeared completely in 31.3% of the patients, disappeared partially in 58.3% and stable in 10.4%. Conclusions: Krypton yellow laser photocoagulation seems prominently effective and safe for the macular edema of diabetic retinopathy.
出处 《中国实用眼科杂志》 CSCD 北大核心 2001年第7期552-553,共2页 Chinese Journal of Practical Ophthalmology
关键词 糖尿病性视网膜病变 激光凝固术 氪黄激光 黄斑水肿 Diabetic retinopathy, Photocoagulation
  • 相关文献

参考文献1

共引文献11

同被引文献48

  • 1马立,于路珍.全视网膜冷凝术治疗增殖型糖尿病视网膜病变[J].中华眼底病杂志,1993,9(3):148-151. 被引量:2
  • 2谢学军,王明芳.糖尿病视网膜病变的病机探讨[J].中国中医眼科杂志,1995,5(2):86-88. 被引量:82
  • 3杨洁.糖尿病性视网膜黄斑水肿氪黄激光治疗的临床分析[J].中国热带医学,2006,6(6):1038-1038. 被引量:2
  • 4严密.眼科学[M]第4版[M].北京:人民卫生出版社,1995.202.
  • 5第二届全国眼科学学术会议[J].中华眼科杂志,1985,21(2):113-113.
  • 6张承芬.眼科新编[M](第1版)[M].北京:人民卫生出版社,1991.411.
  • 7关航.眼科主治医390问[M](第1版)[M].北京:人民卫生出版社,1998.143-148.
  • 8严密 主编.眼科学[M].北京:人民卫生出版社,1995.190-191.
  • 9Aiello LP, Bursell SE,Clermont A,et al. Vascular endothelial growth factor- induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta - isoform - selective inhibitor [J]. Diabetes,1997,46:1473 - 1480.
  • 10Martidis A. Intravitreal triameinolone for refractory diabetic maeular edema [ J ]. Ophthalmology, 2002,109 (5) : 920 - 927.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部